- <![CDATA[Sequencing ADCs in Endometrial Cancer]]><![CDATA[Sequencing therapy in recurrent endometrial cancer is becoming more complicated as immunotherapy moves earlier and antibody drug conjugates gain momentum.]]>onclive · 2mo ago↗ source
- <![CDATA[Second Clinical Scenario - Progressive Disease Despite Hematocrit Control]]><![CDATA[Polycythemia vera symptoms like fatigue and aquagenic itching signal active disease; experts urge objective tracking and tailored therapy beyond phlebotomy.]]>onclive · 2mo ago↗ source
- A year after Vertex’s big launch, pain drug research faces a pivotal moment<p>Journavx revived an area of development long considered a graveyard. Can any other pain drugs keep investor excitement going?</p>BioPharma Dive · 2mo ago